Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Institut Curie
ALX Oncology Inc.
Nagoya City University
Memorial Sloan Kettering Cancer Center
The Netherlands Cancer Institute
Veana Therapeutics
Institut Paoli-Calmettes
Seagen Inc.
Amgen
Medstar Health Research Institute
SCRI Development Innovations, LLC
NKGen Biotech, Inc.
Swiss Cancer Institute
Herlev Hospital
Novartis
Celgene
Novartis
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Daiichi Sankyo
Merrimack Pharmaceuticals
SCRI Development Innovations, LLC
Berufsverband Niedergelassener Gynäkologischer Onkologen in Deutschland e.V.
Novartis
Catharina Ziekenhuis Eindhoven
Vejle Hospital
National Cancer Institute (NCI)
BBB-Therapeutics B.V.
Novartis